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The nuclear progesterone receptor (Pgr) is one of the major mediators for 
progestin signaling during oocyte ovulation in vertebrates. However, any roles Pgr may 
play in oocyte growth, and especially in the final oocyte maturation, are controversial. 
Due to the small size of the oocytes and difficulty in separation of encircled follicular 
cells from oocytes, little information is available on the location and changes of Pgr in 
vertebrates. We study the roles of the Pgr in the ovaries of zebrafish, which release eggs 
daily, by localizing and comparing the changes of Pgr in the oocytes and enclosed 
follicular layers at all developmental stages and from different times of the day or after 
treatment with various hormones.  The pgr transcript and Pgr protein were expressed in 
oocytes and follicular cells of early developmental stages (stage I and II). In contrast, Pgr 
was expressed abundantly in the follicular cells surrounding late developmental stage 
oocytes (stage IV) but completely absent from stage IV oocytes. Furthermore, the most 
significant daily changes of pgr transcript were observed in the stage IV follicular cells 
with the highest level observed at 6 am prior to ovulation and the lowest level at 9 pm. 
 The levels of pgr transcript were upregulated by 17 alpha, 20 beta-dihydroxy-4-pregnen-
3-one (DHP) in both stages of I-II and IV oocytes. Intriguingly, estrogen (E2) and human 
chorionic gonadotropins (hCG) significantly suppressed pgr expression in stage I-II 
oocytes, while enhancing pgr expression in stage IV oocytes. Presence of Pgr in both 
oocytes and follicular cells of early stages (stages I-II) suggest roles of Pgr in oocyte 
growth. Abundant expression and dramatic changes of Pgr in the follicular cells of late 
stage (stage IV) indicate roles of Pgr during oocyte ovulation. Absence and lack of 
changes of Pgr in the stage IV ooctyes do not support the role of Pgr in final oocyte 
maturation.  
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 INTRODUCTION 
 All steroids generate slow genomic signaling via altering transcripts in the nucleus,  
or rapid nongenomic signaling by fast modification of phosphorylation at the cell 
membrane or in the cytosol (Tokumoto et al., 2005; Bhattacharya et al., 2007; Zhu et al., 
2008). The nuclear steroid receptors, including progesterone receptors (PGRs), are major 
receptors for achieving genomic signaling with their ligands, and may also play roles in 
nongenomic signaling of the steroids (Mulac-Jericevic et al., 2000; Conneely et al., 2003). 
Interestingly, a membrane progestin receptor (mPR) belonging to a novel G-protein 
coupled receptor-like receptor family and with no structural similarity to the classical 
steroid receptors mediates rapid nongenomic actions of progestin signaling during oocyte 
maturation in zebrafish and Xenopus (Zhu et al., 2003; Hanna et al., 2006; Josefsberg 
Ben-Yehoshua et al., 2007; Zhu et al., 2008). Similarly, mPR also mediates rapid 
nongenomic actions of progestin in sheep, rats, mice, and human (Ashley et al., 2006; Liu 
and Arbogast, 2009; Nutu et al., 2009; Labombarda et al., 2010). In contrast, any roles of 
PGR in mediating progestin-dependent nongenomic signaling, particularly during oocyte 
maturation, have been questioned (Bayaa et al., 2000; Zhu et al., 2003; Peluso, 2006).  
 
Nuclear Progestin Receptors 
  The nuclear progestin receptor (PGR or nPR) belongs to the superfamily of 
nuclear receptors. Ligand-induced activation causes translocation of the PGR from the 
cytoplasm to the nucleus (and/or intranuclear change in localization) where they affect 
transcription by association with various target gene promoters (Edwards, 2005). 
 2
Progesterone responsiveness itself is primarily controlled by PGR expression (Merlino et 
al., 2007). 
Similar to other steroid receptors, the PGRs consist of a variable amino terminal 
or A/B region, a highly conserved DNA-binding or C region, a variable hinge region (D), 
a conserved ligand-binding or E region, a variable carboxy terminal region and several 
transcriptional activation functions (AF) (Mangelsdorf et al., 1995). The hinge region 
contains nuclear localization and export sequences that allow the receptor to constantly 
shuttle between the nucleus and cytoplasm. Addition of progesterone causes a shift in 
equilibrium towards the nucleus (Edwards, 2005). The zebrafish progestin receptor of 
molecular weight 69KDa identified in our laboratory (Hanna et al., 2010), shares a high 
degree of sequence homology in its ligand- and DNA-binding regions with PGRs from 
other species (Figure 1). 
Multiple isoforms of PGR have been reported in several species of birds, 
mammals, fish, amphibians, and reptiles (Conneely et al., 1989; Kastner et al., 1990; 
Custodia-Lora and Callard, 2002; Liu et al., 2005). The isoforms in birds and mammals 
arise from a single gene as a result of alternative splicing or alternative translation at two 
alternative AUG signals (Kraus et al., 1993). In contrast, the two subtypes of PGR found 
in Xenopus and A. japonica, derive from distinct gene products (Ikeuchi et al., 2001; Liu 
et al., 2005). While the physiological functions of the multiple forms of the PGR are not 
yet fully understood, some evidence suggests that PGR-B is a strong activator of gene 
transcription while PGR-A is a ligand-dependent trans-repressor of PGR-B and other 
nuclear receptors (Edwards, 2005). The existence of two PGR isoforms that create 
functionally different receptors leads to speculation that the transcription of a single gene 
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from multiple promoters provides enhanced control over gene expression (Kastner et al., 
1990). However, since only one PGR has been identified in zebrafish (Chen et al., 2010; 
Hanna et al., 2010), control of gene expression in zebrafish likely reflects ancestral forms 
of regulation. Thus, knowledge of localization, daily changes in expression and hormonal 
regulation of PGR in zebrafish may provide unique knowledge. 
The PGRs are major receptors for mediating genomic effects of progestins at the 
nucleus. Upon activation of a PGR by a progestin ligand, such as 17α, 20β-dihydroxy-4-
pregnen-3-one (17,20β-DHP), a number of events transpire. First, the receptor dissociates 
from its protein chaperones. In the case of PGRs, these associated proteins include Hsp40, 
Hsp70, Hop, Hsp90 and p23  which maintain the PR in a conformational state conducive 
to ligand binding (Cintron and Toft, 2006). After dissociation, conformational changes 
and phosphorylation occur (Camacho-Arroyo et al., 2007). As well, homo- and/or hetero- 
dimerization of the receptor complexes are formed with cofactors that modify chromatin 
organization, the nuclear receptor binds to the hormone response element (HRE) of its 
target gene where further phosphorylation occurs, and the basal machinery of 
transcription is recruited  (Edwards, 2005; Camacho-Arroyo et al., 2007). When no 
longer required, the phosphorylated PR is degraded by the ubiquitin-proteasome pathway 
(Camacho-Arroyo et al., 2002). 
Nongenomic actions of PGRs. The PGR may also mediate nongenomic actions of 
progestins. Both PGR and mPR are able to activate MAPK signaling in target cells 
(Boonyaratanakornkit et al., 2001; Zhu et al., 2003), one requirement for mediating final 
oocyte maturation. In Xenopus, over-expression of xPGR results in the acceleration of 
progesterone-induced maturation (Bayaa et al., 2000) while the addition of anti-sense 
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xPGR oligonucleotides inhibits progesterone-induced maturation (Tian et al., 2000). 
Similar results were also obtained in reptiles (Custodia-Lora and Callard, 2002). 
 However, evidence continues to build to discount a possible role for PGR in 
nongenomic actions. First, nongenomic actions require PGR to localize at the surface of 
the oocyte membrane (Thomas, 2008; Zhu et al., 2008). Small quantities of xPGR-1 
(~5%) have been shown to be present in oocyte membrane fractions by Western blot 
(Bagowski et al., 2001). However, membrane localization of the Xenopus PGR has not 
been detected despite efforts by other groups (Bayaa et al., 2000; Tian et al., 2000). Also, 
nongenomic actions are characterized by rapid signaling. Measurements of 
dissociation/association rates for the seatrout mPR (<10 minutes) and PGR (1-1.5 hours) 
undermine PGR as key mediator of these actions (Zhu et al., 2008). Finally, the PGR 
antagonist RU486 weakly induces oocyte maturation and fails to block progesterone in 
Xenopus (Edwards, 2005). 
Genomic actions of PGRs during ovulation. The transcription of PGR and several other 
ovarian genes associated with ovulation are enhanced by GnRH and LH/hCG (Kang et 
al., 2003; Motola et al., 2006). This increase in PGR is important as steroid-dependent 
ovulation involves genomic mechanisms regulated by a nuclear receptor (Pinter and 
Thomas, 1995). Progesterone action occurring through genomic mediation is critical for 
ovulation in non-mammalian species, such as frogs and at least several teleost fishes 
(Goetz and Theofan, 1979; Schuetz and Lessman, 1982; Pinter and Thomas, 1995) 
Progesterone also plays important functions in ovulation in mammalian species. PGR-A 
is necessary to mediate the ovulatory response to progesterone in mice (Conneely et al., 
2002). In rats, progesterone is able to control the timing of ovulation by modulating the 
 5
expression of adenylate cyclase activity in granulosa cells (Graham and Clarke, 1997; Ko 
and Park-Sarge, 2000). The presence of PGRs in most follicular cell types provides 
support that the process of ovulation is regulated by progesterone (Graham and Clarke, 
1997). Finally, PGR knockout (PGRKO) and PGR- A knockout (PGRAKO) mice are 
unable to ovulate despite forming oocytes that develop normally and are fertilizable 
(Lydon et al., 1995; Conneely et al., 2002; Kim et al., 2009). 
PGR isoforms. As mentioned, the PGR isoforms appear to have distinct physiological 
roles. The ratio of PGR-A to PGR-B can vary significantly according to cell type and 
physiological conditions, even though the two PGR isoforms are co-expressed in tissues 
(Edwards, 2005) and this differential expression contributes to cell-specific responses 
(Turgeon and Waring, 2006). It is interesting that differential expression of PGR isoforms 
in the follicular layer of cells versus the oocyte has been noted in Xenopus (Liu et al., 
2005), but the relative expression of PGR-A to PGR-B in oocytes has not been described 
in any fish species. 
Since zebrafish has only one identified pgr, regulation may occur differently than 
in species containing multiple isoforms. For instance, in mammary tissue of 
ovariectomized mice PGR-A is extensively co-localized with estrogen receptor (ERα) 
and its’ expression is increased in the presence of estrogen suggesting direct regulation of 
PGR-A by ERα (Aupperlee and Haslam, 2007). On the contrary, PGR-B is not co-
localized with ERα and induction of PGR-B expression coincided with decreased PGR-A 
levels and increased progesterone levels (Aupperlee and Haslam, 2007). Determining the 
effect of estrogen and progesterone in a species containing only one form of PGR, such 
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as the zebrafish, may provide insight into the evolutionary costs or benefits of a multiple 
isoform system.  
Furthermore, PGR-A and PGR-B exhibit distinct trans-activation properties when 
expressed individually with PGR-A able to act as a strong trans-dominant suppressor of 
PGR-B (Giangrande et al., 2000). Perhaps, regulation of zebrafish PGR will require 
mediation through slightly different biochemical pathways than other species. However, 
differential interactions with co-regulators, despite identical ligand-binding domains, and 
the ability of different ligands to induce distinct conformational changes in each PGR 
isoform affect transcriptional regulation (Conneely et al., 2002) so this provides one path 
of differential regulation by the same isoform. 
Cellular expression and localization of nuclear progesterone receptor (PGR) in 
ovaries. It is known that progestin plays an invaluable role in reproductive function and 
PGRs are found in many reproductive tissues, including the ovaries and the testes. In 
Xenopus, the PGR subtypes are known as xPGR-1(~80 kDa) and xPGR-2 (~70 kDa) (Liu 
et al., 2005). In stage VI oocytes, xPGR-1 was identified in the follicular cells while 
xPGR-2 was expressed mainly in the nucleus of oocytes (~74% of total), but also in the 
cytoplasm of oocytes (~21%) (Liu et al., 2005). In turtles, PGR-A has been detected in 
the ovary and kidney, PGR-B in the gastrointestinal tract and both isoforms in the heart 
and spleen (Custodia-Lora and Callard, 2002). The tissue distributions of two PGR 
subtypes in A. japonica were clearly different from one another. ePGR2 mRNA was 
detected in gill, spleen, testis, brain, and ovary while ePGR1 mRNA was observed in 
kidney, spleen, liver, and testis (Ikeuchi et al., 2002). In other non-mammalian species, 
PGRs have been detected mainly in oviduct of chicken (Conneely et al., 1989) and ovary 
 7
of seatrout (Pinter and Thomas, 1995). In mammals studied to date, PGRs have been 
identified mainly in uterus and ovary with expression in the ovary restricted primarily to 
granulose cells of follicles (Graham and Clarke, 1997; Robker et al., 2009). However, no 
study has been done on the localization and comparison of PGR in follicular cells and 
oocytes in vertebrates with the exception of Xenopus (Bagowski et al., 2001). 
 Nuclear PGRs are generally associated with genomic actions that occur inside of 
the nucleus in cells.  However, it has been proposed that rapid nongenomic actions, such 
as those seen in oocyte maturation, may be mediated through association of these 
classical receptors with the cell membrane (Bagowski et al., 2001). For instance, post-
translational modification of the receptor could impart the ability to associate with the 
plasma membrane which would make sense if nuclear PGRs have a role in nongenomic 
signaling (Edwards, 2005). Also, interaction of PGRs with trafficking proteins could 
result in translocation to the oocyte membrane (Edwards, 2005). 
 Studies of PGRs in ovaries have generally been limited to immunohistochemical 
and in situ localization because the use of biochemical and molecular analyses of PGR 
changes are challenging and unreliable due to difficultly in separation of oocytes from the 
follicular layer of cells. Previously, chemical removal of the follicles has not proven 
reliable and the complete removal of the follicular layer has been difficult to verify. 
Additionally, the accepted means of removing the follicular layer, through mechanical 
removal by forceps, has proven time-consuming and has limited study to oocytes in later 
stages of development. Also, damage to the oocyte membrane during this process could 
result in yolk proteins leaking out of the oocyte and being collected along with the 
follicular layer which could interfere with accurate quantification and localization of the 
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PGR transcripts. Furthermore, damage caused to the oocytes during this process could 
lead to degradation of the transcripts and protein, thus inhibiting detection of the PGRs. 
The protocols for chemical and mechanical removal of the follicular cells were developed 
in the current study to ensure this novel procedure produced results consistent with the 
proven, though arduous, procedure. 
 Determining the cellular localization and changes of PGRs in two cellular 
compartments, i.e. oocytes and follicular cells, is important so that the signaling pathways 
and molecules mediated by the PGRs can be correctly identified. Specifically, cellular 
localization and changes provide evidence for roles of PGRs in genomic (i.e. oocyte 
growth, ovulation) and/or nongenomic actions (i.e. oocyte maturation). 
Changes of the PGR during oocyte growth, maturation and ovulation. The 
expression of PGR transcript and protein has been shown to change during different 
phases of the reproductive cycle in humans and chickens (Graham and Clarke, 1997). 
This demonstrates the importance of regulation of PGRs for proper reproductive function. 
In species with two PGR isoforms, such as humans, chickens, and mice, the levels of both 
isoforms may change independently of one another altering their relative abundance and 
providing support for the hypothesis that PGR expression levels are physiologically 
relevant (Punyadeera et al., 2003; Gava et al., 2004; Camacho-Arroyo et al., 2007). 
Additionally, chicken PGRs’ expression levels differ among progestin target tissues and 
according to different hormonal and environmental conditions such as those experienced 
during avian sexual maturity and the seasons of the year (Camacho-Arroyo et al., 2007). 
During the turtle reproductive cycle, the level of PGR-A protein remains constant in the 
ovary, but PGR-B protein levels go through several cycles of increase and decrease 
 9
(Custodia-Lora and Callard, 2002). In humans, the A:B ratio in lower segment 
myometrium changes from approximately 0.5:1 in preterm specimens to around 1:1 at 
term and more than doubles to 2.5:1 during labor, mostly due to increases in levels of 
PGR-A (Merlino et al., 2007). Variances in the relative expression of the isoforms at 
different points in the reproductive cycle has also been demonstrated in the Rhesus 
Macaque and in mice (Bethea and Widmann, 1998; Gava et al., 2004). 
 Several studies have postulated that variance in the expression of the PGR 
isoforms, particularly with regards to their relative abundance to one another, plays an 
important role in the processes of oocyte growth, maturation and ovulation. In humans, 
variance in the abundance of PGR isoforms is easily explained as different promoters in 
the PGR gene exhibit differential regulation (Bethea and Widmann, 1998). According to 
Merlino et al. (2007), the extent of PGR-A repression of PGR-B in most cells is directly 
related to the relative abundance of each. Thus far we have identified only one pgr in 
zebrafish, but it is likely that this single pgr gene plays a similar physiological role to 
PGRs from other species. Therefore it is important to determine whether the zebrafish 
PGR undergoes similar environmental- and hormone- dependent changes in its 
expression levels and the mechanism of its regulation during the zebrafish daily 
reproductive cycle. 
Hormonal regulation of the PGRs. As PGR is an important mediator of progestin 
function, it is crucial to understand its regulation by hormones. Hormones involved in the 
direct and indirect regulation of PGRs include follicle-stimulating hormone (FSH), 
leutinizing hormone (LH), estrogens and progestins (Beato et al., 1995; Jalabert, 2005; 
Drummond, 2006). 
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 The gonadotropins FSH and LH are key factors in ovarian and follicle 
development. The expression of FSHR mRNA occurred during the recruitment and 
growth of follicles while LHR mRNA expression increased during final oocyte 
maturation and ovulation (Kwok et al., 2005). Additionally, in vivo experiments with 
several teleost species have linked estradiol to increased expression of LH mRNA in the 
pituitary gland (Aroua et al., 2007). Teleost maturation-inducing hormone (MIH), which 
is necessary for oocyte maturation, is synthesized in the follicles under the control of LH 
(Jalabert, 2005). In zebrafish and other teleost species, the MIH is 17α, 20β-dihydroxy-4-
pregnen-3-one (17,20β-DHP) and it is a potent inducer of Pgr-mediated transcriptional 
activity (Todo et al., 2000; Hanna et al., 2010). LH-dependent release of MIH results in 
activation of PGRs . The induction of PGR-A and PGR-B in preovulatory follicles in 
response to LH has also been demonstrated in mice (Natraj and Richards, 1993) and it is 
understood that the ability of LH to stimulate transient expression of PGR mRNA and 
proteins is necessary as follicle rupture is LH-dependent (Conneely et al., 2002). Thus, 
LH plays an important role in regulating oocyte maturation and ovulation. As such, its 
effects on PGR expression need to be studied. 
In several mammalian and bird tissues, expression of PGR is positively controlled 
by estrogen and negatively impacted by progesterone in most target tissues (Graham and 
Clarke, 1997). Estrogen is a known inducer of PGR-A and PGR-B transcriptional activity 
(Punyadeera et al., 2003). Boney-Montoya et al. (2010) have identified a number of 
estrogen response elements (EREs) in PGR gene that allow for dynamic regulation of the 
PGR expression. In a study on ovariectomized mice, the addition of estrogen up-
regulated PGR-A and enhanced progesterone-induced increase of PGR-B while 
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progesterone down-regulated PGR-A (Aupperlee and Haslam, 2007). In vitro studies 
have demonstrated the ability of progestin treatment to effect levels of PGRs. In Xenopus, 
treatment of isolated follicle cells with progesterone results in the degradation of xPGR-1 
(Liu et al., 2005). 
Elucidation of the possible roles of FSH, LH, estradiol, progesterone and its 
derivatives (i.e. 17,20β-DHP), a maturation-inducing steroid in zebrafish, in the hormonal 
regulation of PGR during the processes of oocyte growth, maturation and ovulation in the 
zebrafish will be accomplished by the addition of these hormones under in vitro 
conditions.   
Difficulties in study of PGRs. The inability to collect completely denuded stage I-III 
oocytes for detection of PGR transcripts and proteins by PCR and Western blotting, 
respectively, has limited study in the field to mature oocytes. To my knowledge, this 
study would be the first to specifically localize PGR in early and late developmental 
stages of oocyte at various times throughout the zebrafish daily reproductive cycle. The 
elucidation of the molecular mechanisms that promote oocyte growth, maturation and 
ovulation has potential applications for improving fertility and for in vitro culture systems 
for oocytes from domestic animals and humans (Thomas and Vanderhyden, 2006). 
 
 
 
 
 
 MATERIALS AND METHODS 
Defolliculation of Oocytes 
Zebrafish, obtained from a local pet store, were sacrificed by decapitation and ovaries 
were extracted and immediately placed in 5 mL 50% L15 media in 6cm x 1.5cm Petri 
dishes. Samples were gently pipetted up-down several times to separate individual 
oocytes for collection according to the stage of development. Oocytes were separated as 
early stage (stage I-II Ø=100-200 µm) or late vitellogenic stage oocytes (stage IV Ø=500-
625 µm) determined by a micrometer under a stereomicroscope (Nikon) and transferred 
into separate petri dishes for defolliculation treatment. Prior to defolliculation treatment, 
total oocytes including follicular cells and enclosed oocytes from each stage of 
development were collected, placed in TRIzol reagent (Life technologies), homogenized, 
and frozen immediately for total RNA extraction at a later time. 
50% L15 media was removed from the samples and replaced with 5mL 0.001% 
collagenase (Sigma-Aldrich) in Ca2+-free Ringer’s solution (116mM NaCl, 2.9mM KCl, 
5mM HEPES, pH 7.2). All samples were shaken at 60 RPM for one hour and fifteen 
minutes at room temperature. Additionally, the samples were gently pipetted for three 
minutes during each ten minute period. The late stage vitellogenic oocytes were pipetted 
with a 9” disposable Pasteur pipette (Fisher Scientific) (Ø=1000 µm tip opening), while 
the stage I-II sample was pipetted using a pipette with a smaller (Ø=300 µm) opening. 
The smaller pipette was made by heating a pipette tip over a Bunsen burner and 
stretching the glass to create a narrower tip. During the one hour and fifteen minute time 
period, free stage IV follicular layer was verified under a stereomicroscope and collected 
by pipette after each pipetting period.  
 13
After the one hour and fifteen minute time period, the follicular cells were carefully 
removed from Ringer’s solution using a pipette while viewing underneath a 
stereomicroscope to ensure that no oocytes were collected. The follicular cells were 
placed in separate 1.5 mL microcentrifuge tubes and centrifuged for 1 minute at 13000 
RPM (Eppendorf Centrifuge 5415D) to collect the follicle cells. The supernatant was then 
discarded. 
The stage I-II and stage IV oocytes collected above were washed twice in Ringer’s 
solution to remove any free follicle cells. Next, they were stained by the addition of 1 µL 
of propidium iodide (20 µg/mL, Sigma) in 3 mL of Ringer’s solution into the petri dishes 
for a period of 15 minutes. The samples were washed twice in Ringer’s solution and the 
oocytes were examined under the fluorescent inverted microscope (Axiovert 200M, Zeiss) 
to verify the removal of the follicular layer of cells from the oocytes. Stage I-II and stage 
IV completely denuded oocytes (100% removal of follicular layer) were selected off and 
placed into new 1.5 mL microcentrifuge tubes.  
Total RNA Isolation 
The sonicator tip was cleaned in 10 M NaOH for 15 minutes and rinsing with 
distilled water prior to tissue homogenization. Additionally, the sonicator tip was rinsed 
with distilled water and sequentially dipped in ten sterilized deionized water bathes 
between homogenization of each sample. The Ringer’s solution was removed from the 
collected samples and 500 µL of TRIzol Reagent was added. Samples were immediately 
homogenized using a sonicator (Sonic Dismembrator Model 100, Fisher Scientific) and 
purified following the manufacturer’s instructions.  The concentration of total RNA 
extracted from each sample was quantified using a biophotometer (Eppendorf). 
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RT-PCR 
First-strand cDNA was synthesized utilizing the Superscript First-Strand 
Synthesis System for RT-PCR (Invitrogen) following the manufacturer’s instructions.  
The same quantity of RNA was run on a gel to check for degradation and to ensure that 
the quantity of RNA used to synthesize cDNA was equal. The 10 µL reaction consisted 
of 4 µL total RNA (0.5 µg), 0.5 µL 10 mM dNTP, 0.5 µL oligo dT primer (0.5g/L), 1 
µL10X RT Buffer, 2 µL 25 mM MgCl2, 1 µL 0.1 M DTT, 0.5 µL RNase Out 
Recombinant Phase RNase Inhibitor and 0.5 µL (25 units) Superscript II Reverse 
Transcriptase.  After the reaction was terminated and inactivation of RNase Out, 0.5 µL 
(1 unit) RNase H was added to each sample. 
Gene specific primers for PGR were utilized to amplify cDNA from oocytes and 
follicular cells. Each 10 µL PCR reaction mixture consisted of 4.15 µL deionized water, 2 
µL Green Taq Polymerase 5X Buffer (Promega), 0.6 µL 25 mM MgCl2, 0.2 µL 10 mM 
dNTP, 1 µL each of 100 nM gene-specific forward and reverse primer, 0.05 µL GoTaq 
Flexi DNA Polymerase (Promega) and 1 µL cDNA.  The reactions were carried out in a 
Mastercycler gradient machine (Eppendorf) under the following PCR conditions: 95 oC 
for 2 minutes, 30 cycles at 95 oC for 30 seconds, 56 oC for 30 seconds, 72 oC for 1 minute 
followed by a 10 minute elongation time at 72 oC. 
For RT-PCR, each sample was run with primers for PGR and β-actin (Figure 5). β-
actin was used to confirm that cDNA synthesis was successful and that equal amounts of 
cDNA were used for the RT-PCR reaction. 
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in situ Hybridization 
Preparation of Probes for in situ 
 PGR cDNAs were linearized with SpeI or SphI to generate templates for 
synthesizing sense or antisense probes, respectively. Sense and antisense digoxigenin-
labeled probes were generated using T7 or SP6 RNA polymerases by in vitro 
transcription according to the instructions of the manufacturer (Roche Applied 
Science, Indianapolis, IN). 
Sectioning for in situ Hybridization  
 Whole ovaries were removed and fixed in 4% paraformaldehyde–PBS overnight. 
The tissues were dehydrated, embedded in paraffin, cut into 5–8 µm thick sections 
and serially mounted on Superfrost slides (Fisher Scientific, Pittsburgh, PA). 
in situ Hybridization 
 Previous in situ protocol were followed (Zhu et al., 2007). In brief, sections were 
processed, re-hydrated, post-fixed with 4% paraformaldehyde for 20 minutes, and 
then treated with 200mM HCl for 10 minutes followed by 15 minutes digestion of 10 
µg/mL protein kinease K. Hybridization was conducted with a digoxigenin-labeled 
probe (10 ng/probe/slide) in 60 µl buffer (50% deionized formamide/2x SSC/10% 
Dextran sulfate/0.01% yeast RNA/0.02% SDS) overnight at 55°C. Sections were 
washed in high-stringency buffer (1x SSC/50% formamide) at 55°C and 1x SSC at 
room temperature. Sections were then equilibrated with TBS (50mM Tris, pH 7.5, 
150mM NaCl) and blocked with 1x Roche blocking solution containing 10% fetal 
bovine serum and 1% sheep serum in maleic buffer (100mM maleic acid, 150mM 
NaCl, pH 7.5) for 1 hour at room temperature. To develop the color, sections were 
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incubated for 1 hour with anti-digoxigenin–AP (Roche Applied Science), diluted 
1/2000 with 1x Roche blocking solution containing 10% FCS at room temperature. 
Sections were washed with TBS, equilibrated in AP buffer (pH 9.5) and incubated 
with NBT/BCIP substrate (Roche Applied Science) for a few minutes to a few hours 
at 37 °C in a dark humid chamber. The development of the substrate was examined 
under a microscope and reactions were stopped by washing with TE buffer (10mM 
Tris, pH 7.5, 1mM EDTA) twice, then fixed with 4% paraformaldehyde, washed 
twice with TE buffer, and mounted with 90% glycerol in PBS. 
Quantitative Real-Time PCR (qRT-PCR) 
Preparation of Standard Curve 
 Plasmid DNAs containing full length pgr cDNA inserts were quantified using a 
DNA/RNA calculator followed by serial dilution of the plasmids from 103 to 109 
times. The concentrations of undiluted plasmids were 0.100 µM. A growth curve 
based upon the amount of fluorescence detected at each cycle number was created 
using SmartCycler software (Cepheid, Sunnyvale, CA). A standard curve was created 
by using the critical threshold (Ct) value, determined from this growth curve, and the 
log concentrations of the serially diluted standards. The cDNA standards were 
measured three separate times to ensure reproducibility. 
qRT-PCR Conditions 
 The pgr concentrations in the samples were determined  using quantitative real-
time PCR (qRT-PCR) with SYBR green dye (Stragtagene, La Jolla, CA) in a Cepheid 
SmartCycler MX4000 (Cepheid, Sunnyvale, CA). The PCR mixture consisted of 1x 
Cepheid enhancer additive (1mM Tris, pH 8.0; 0.1 mg/mL bovine serum albumin, 
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non-acetylated; 0.75M trahalose; 1% tween-20), 10 µL MasterMix (2.5x, Eppendorf), 
500 nM forward and reverse primers and 0.25x SYBR green dye. 
 The PCR conditions were 95 oC for 2 minutes followed by 30-40 repeats at 95 oC 
for 15 seconds, 60 oC for 30 seconds and 72 oC for 30 seconds. 
Calculation of pgr Concentrations in the Samples  
 Ct values for each sample were determined by the BRAND software. The initial 
concentrations of pgr were interpolated from the standard curve and converted to 
fmol/µg total RNA. 
Immunological Analysis 
Production of Polyclonal Antibody for Pgr 
Rabbits generated polyclonal antibodies against four synthetic peptides 
corresponding to the N-terminal (aa 74-87, aa 100-112) or C-terminal (aa 466-479, aa 
519-532) part of zebrafish Pgr. The peptides were designed to have low/no homology 
to other zebrafish proteins and a strong immuno-response was ensured by linking the 
peptides to keyhole limpet hemocyanin (KLH) to increase the size of the antigen. A 
N-terminal antibody (aa 100-112) was confirmed to be specific and subsequently used 
for Western blotting and immunohistochemical (IHC) localization.  
Fixation and Embedding 
Ovary samples were collected at various time points throughout the zebrafish’s 
reproductive cycle and immediately placed in 10% buffered formalin upon 
dissection from the zebrafish. Samples were left overnight at room temperature 
(~21 oC).  After overnight fixation, the samples were dehydrated in a series of 
ethanol washes (70%, 95%, 100%), twice for 30 minutes each. This was followed 
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by washes in xylene (15 minutes), xylene:methyl salicytate (1:1- 30 minutes), 
methyl salicytate (30 minutes) and three paraffin washes at 60 oC for 1 hour each. 
Tissues were embedded in paraffin and placed in the refrigerator (5 oC). Samples 
were cut into 8 µm sections using a microtome (Reichert-Jung 2030, Leica, 
Germany). The sections were positioned on labeled microscope slides with albumen 
fixative and Milli-Q water.  Slides were dried on a hot plate (42 oC) overnight.  
Immunostaining 
Slide samples had paraffin removed and were rehydrated by the following series 
of washes for 5 minutes each: xylene, 100% ethanol, 95% ethanol, 70% ethanol and 
1X PBS. Next, sections were incubated in 0.3% hydrogen peroxide (H2O2) in 100% 
methanol for 30 minutes followed by 3 washes in 1X PBS for 5 minutes each. 
Slides were placed on slide plates and covered with diluted normal serum 
(Vectastain ABC Kit, Vector Laboratories) for 30 minutes. Excess serum was 
washed off and slides were placed on slide plate with primary antibody serum 
(1:250 dilution). The slide plate was placed in a humidity chamber and left 
overnight at 4 oC.  The next morning the slides were carefully rinsed with distilled 
water and washed four times in 1X PBS for 3 minutes per wash. Then, the sections 
were incubated in diluted biotinylated antibody solution (Vectastain ABC Kit, 
Vector Laboratories) for 30 minutes and washed 3 times in 1X PBS for 5 minutes 
per wash. Sections were placed back on slide plate with Vectastain ABC reagent 
(Vectastain ABC Kit, Vector Laboratories) for 30 minutes and then washed 4 times 
with 1X PBS for 5 minutes per wash. The peroxidase substrate solution (100 mg 
diaminobenzidine, 64 µL 30% H2O2 and 200 mL Tris Buffer [50 mM Tris, pH 7.2]) 
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was prepared immediately prior to slide development. Following development, 
sections were placed in 1X PBS for at least 5 minutes, then dehydrated through a 
series of ethanol washes (70%, 95%, 100%) and xylene for 5 minutes each before 
mounting with a coverslip using Permount.   
Western Blotting 
     Total protein was collected from ovary samples placed in 1X SDS in 1.5 mL 
microcentrifuge tubes immediately upon removal from zebrafish. The sonicator 
probe was cleaned with 70% ethanol and rinsed with distilled water prior to 
homogenization of sample.  After homogenization samples were boiled for 10 
minutes and placed on ice.  
Statistical Analysis 
Statistical analysis was performed using SPSS 14.0 (SPSS Inc., Chicago, IL). 
Descriptive statistics were used to determine means and standard deviations of log 
concentrations of pgr mRNA at various time points and after hormone treatments.  
Analyses of variance (ANOVAs) were conducted to determine the significance of 
mean differences between various treatments. Paired t-tests were performed to 
compare the effects of various hormone treated oocytes to a control. A significant  p 
value was set at α = .05. 
 
 
 RESULTS 
Separation of Follicular Cells and Oocytes from Early (stage I-II) and Late (stage IV) 
Vitellogenic Oocytes  
After collagenase treatment of oocytes, separation of the follicular layer from oocytes 
was verified with propidium iodide staining (Figure 3). Propidium iodide staining and 
collection procedures had no negative impact on the integrity of the RNA used for cDNA 
synthesis and amplification of pgr from stage I-II denuded oocytes (Figure 4). 
Almost all oocytes had their follicular layers removed via the combination of 
chemical and mechanical treatment. While the standard 9” disposable glass pipette 
worked well for removing the follicular layers from late stage vitellogenic oocytes, a 
smaller pipette size (0.3 mm) was necessary to facilitate the removal of the follicular 
layer from early stage vitellogenic oocytes. 
Expression of pgr in Follicular Cells and Denuded Oocytes Analyzed by RT-PCR 
 The pgr transcripts were detected in follicular cells and denuded oocytes of early 
developmental samples (stage I-II) by RT-PCR (Figure 5). In late (stage IV) vitellogenic 
oocyte samples, pgr transcripts were detected in follicular cells only (Figure 5). These 
results correspond with our in situ localization and immunocytochemical analyses 
described below. 
Expression of pgr in Follicular Cells and Denuded Oocytes Analyzed by in situ 
Hybridization 
 The pgr transcripts were detected in the follicular layer of late stage oocytes by in 
situ hybridization using a zebrafish pgr antisense probe. The pgr transcript was restricted 
to the follicular layers with no detectable signaling within the late stage oocytes (Figure 
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6). Interestingly, the pgr transcript was also observed in the cytoplasm of early stage 
oocytes (stages I and II) (Figure 6).  
Expression of Pgr in Follicular Cells and Denuded Oocytes Analyzed by Western 
Blotting and Immunocytochemistry  
The Pgr protein (69 kDa) was detected by Western probing in early stage 
vitellogenic oocyte samples (not shown) and late stage vitellogenic follicular samples 
using a zebrafish Pgr antibody (Figure 7). 
 Specific immunocytochemical staining of Pgr was observed only in the nuclei of 
follicular cells surrounding late stage vitellogenic oocytes (Figure 8). This corresponded 
to results seen in the Western blotting, in situ, and RT-PCR where the Pgr protein and pgr 
transcripts was only detected in the follicular cells of late stage vitellogenic oocytes. Thus, 
it seems likely that the 69 kDa band representing the zebrafish Pgr is localized 
specifically to the nucleus of the stage IV follicle cells. 
Daily Changes of pgr in Follicular Cells and Denuded Oocytes 
 Changes in the daily expression of pgr mRNA was determined using quantitative 
real-time PCR (qRT-PCR) (Figure 10). In late stage oocytes, pgr transcripts expression 
decreased slightly, but not significantly, at the 1pm and 9pm time points versus the 6am 
time point. Expression in early stage oocytes was significantly lower at 6am versus 1pm 
[F(2,9)=8.91, p=.014]. In late stage denuded oocytes, expression appeared much lower 
than in late stage oocytes or late stage follicle cells. Expression of pgr transcripts was 
significantly lower at 6am versus 1pm [F(2,9)=8.44, p=.015]. Significant differences in 
pgr expression were found between all time points in the follicular cells. Expression 
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decreased significantly from 6am to 1pm [F(2,9)=58.58, p=.012], 1pm to 9pm 
[F(2,9)=58.58, p<.001], and 9pm to 6am [F(2,9)=58.58, p<.001]. 
 Daily changes in Pgr expression were assessed using Western blotting. However, 
the quality of the results did not allow quantification.  
Hormonal Effects on pgr Expression  
Changes in pgr expression in early and late stage oocytes (with intact follicular 
layers) were determined after 1.5 hours and 3 hours of in vitro hormonal treatment 
(Figure 11). No significant differences in expression were seen in late stage oocytes 
between the control and treatment with 17,20β-dihydroxy-4-pregnen-3-one (DHP), 
estrogen (E2), progesterone (P4), or human chorionic gonadotropin (hCG) after 1.5 hours. 
After 3 hours, pgr mRNA expression appeared to increase with DHP, E2, and hCG 
treatments, but the change was not significant.  
 No significant differences in expression were seen in early stage oocytes between 
the control and treatment with 17,20β-dihydroxy-4-pregnen-3-one (DHP), progesterone 
(P4), or human chorionic gonadotropin (hCG) after 1.5 hours. However, E2 significantly 
decreased pgr mRNA expression after 1.5 hours [t(2)=7.17, p=.019].  After 3 hours, pgr 
mRNA expression appeared to increase with DHP and P4 treatments, but the change was 
not significant. 
 Using Western blot analysis, changes in pgr mRNA expression in early and late 
stage oocytes were determined after 1.5 hours and 3 hours of hormonal treatment (Figure 
12). In late stage oocytes, P4 significantly up-regulated pgr expression after 1.5 hours 
[t(2)=-12.529, p=.006]. Treatment with hCG also resulted in a significant increase in pgr 
expression after 1.5 hours [t(2)=-5.119, p=.036]. Expression levels increased with E2 
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treatment as well but not significantly. No significant differences were seen after 3 hours 
of treatment. 
 Expression of Pgr increased after 1.5 hours of treatment with P4 but not 
significantly. No significant differences were seen after 3 hours of treatment though Pgr 
expression appeared to increase with E2 and P4. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 DISCUSSION 
Presence of pgr in follicular cells and denuded oocytes 
Unlike many other animal models, a single locus encoding only one full-length 
zebrafish pgr has been identified (Hanna et al., 2010). In the current study, pgr mRNAs 
and Pgr protein were detected in early developmental and late vitellogenic oocyte 
samples by RT-PCR, in situ hybridization, Western blotting and immunocytochemical 
analyses. These results are expected as Pgrs are known to be present in the ovaries and 
total oocyte samples included both the follicular layer and the oocyte itself (Chen et al., 
2010; Hanna et al., 2010). In early stage oocyte samples, pgr transcripts and Pgr protein 
were detected in the follicular cells and denuded oocyte. These results correspond to 
those of Hanna et. al (2006) who detected Pgr protein in the follicular layer and oocyte 
nucleus of stage I-II oocytes using immunohistochemistry. Follicles from late vitellogenic 
(stage IV) oocytes contained abundant pgr mRNA and Pgr protein. Relatively small 
amounts of pgr transcripts, but not protein, were rarely detected in denuded-late 
vitellogenic oocytes by PCR. However, these amounts were much less than those found 
in early or late stage vitellogenic follicular cells and not supported by our in situ and 
immunohistochemical results. Detection of any pgr transcripts in denuded oocytes is 
likely due to the contamination of trace amounts of follicle cells in the denuded oocyte 
samples and excessive cycles of PCR.  
It is interesting to note that the amount of pgr transcript increased from early stage 
to late stage follicles. Possibly this involves a mechanism preparing the oocytes for 
ovulation. In mice, the presence of PGR-A in the granulose cells of preovulatory follicles 
has been shown to be necessary for successful ovulation (Gava et al., 2004). In fact, 
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studies of mouse models have demonstrated that PGR-A plays the prominent 
physiological role in the uterus and ovary with PGR-B being more important in the 
mammary gland (Edwards, 2005). Thus, the detection of pgr transcripts in stage IV 
follicular cells may be explained by the requirement of Pgr in immature oocytes for 
ovulation. Additionally, in bovines, PGR-A plays a role in mediating apoptosis of 
preovulatory follicles (Quirk et al., 2004). Up-regulation of PGR prior to ovulation may 
facilitate survival of embryos by increasing their resistance to apoptosis. Friberg et al. 
(2010) have identified novel, early gene targets of PGR that may be involved in the 
mediation of apoptosis.  
Daily changes in pgr expression 
Expression of pgr mRNA in early stage oocytes was significantly lower at 1pm 
versus 6am and 9pm. It is probable that pgr mRNA expression is high at 6am as 
previtellogenic and early stage oocytes begin preparing for and beginning vitellogenesis. 
For instance, a period of intense RNA synthesis characterizes the initial stages of primary 
oocyte growth (Tyler and Sumpter, 1996; Lubzens et al., 2010). However, while this has 
received considerable study in amphibians (Wallace and Selman, 1990), there is less 
information available about RNA synthesis activities in the oocytes of teleosts (Tyler and 
Sumpter, 1996). 
Overall, pgr expression appeared much lower in denuded-late stage oocytes 
compare to folliclular cells of same developmental stage, and detection of pgr transcripts 
did not occur until >30 cycles of PCR. This finding agrees with our in situ and 
immunohistochemical results. Additionally, as pgr is not expected to play a direct role in 
oocyte maturation (Hanna and Zhu, 2009, Hanna et al., 2010), a process that is mediated 
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through a G-coupled receptor at the surface of the oocyte, having very little, if any, pgr 
mRNA expression in denuded oocytes makes physiological sense. In late stage oocytes, 
pgr mRNA expression decreased slightly, but not significantly, at the 1pm and 9pm time 
points versus the 6am time point. In contrast, significant differences in pgr expression 
were found between all time points in the follicle cells collected from late stage oocytes. 
In particular, the highest levels of transcripts were detected at 6am which is just prior to 
oocyte ovulation and fertilization. The difference in results between oocyte and follicle 
cell samples may be explained by equal amounts of total RNA being used for PCR. Since 
late stage oocytes contain vast amounts of maternal mRNAs (Tyler and Sumpter, 1996; 
Lubzens et al., 2010), pgr mRNA from oocyte samples was greatly diluted relative to 
follicle cell samples. As published from this study, expression of pgr mRNA was 
localized to the oocyte and follicular layer of early stage oocytes and exclusively to the 
follicular layer of cells in late stage oocytes by in situ hybridization (Hanna et al., 2010). 
Since Pgr plays a role in oocyte growth and ovulation, processes mediated by the 
follicular layer of cells (Lubzens et al., 2010), the daily changes in expression observed in 
follicular cells concur with observations from other studies. Transcription ceases in many 
vertebrate oocytes prior to fertilization (Moore et al., 1974; LaMarca et al., 1975; Tan et 
al., 2009). In mice, genes remain silenced during meiotic maturation and even after 
fertilization (Abe et al., 2010). If transcription is silenced similarly in the zebrafish, it 
would make sense that levels of pgr transcripts, due to its importance in ovulation, are 
expressed in high levels just prior to this silencing. Nagahama and Yamashita (2008) 
postulate that maturation inducing steroid (MIS) upregulation of Pgr may be a key step in 
the ovulatory process of teleosts.  Further studies could provide evidence for this 
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hypothesis by determining whether the amounts of pgr transcripts remain stable and Pgr 
protein expression increases after maturation and fertilization. In summary, since 
progesterone is an important mediator of female reproductive activity (Conneely et al., 
2003) and many of its actions are controlled by PGR (Conneely et al., 2002), better 
understanding of the daily changes in expression levels of these receptors provides 
valuable insight into reproductive functioning. 
Hormonal regulation of pgr 
Expression of Pgr protein significantly increased after 1.5 hours of P4 treatment. 
This result is somewhat counterintuitive as increased levels of P4 normally serve as a 
stimulus to decrease Pgr expression (Liu et al., 2005). In isolated Xenopus follicles and 
rat gonadotropes progesterone treatment leads to Pgr degradation, presumably through a 
proteasome-mediated pathway (Turgeon and Waring, 2000; Liu et al., 2005) while 
another study demonstrated little effect of P4 on Pgr expression (Xiao and Goff, 1999) 
However, P4 is able to induce expression of PGR-B in the mouse mammary gland,, but 
only after prolonged treatment (Aupperlee and Haslam, 2007). It is important to note that 
these findings occurred in species with multiple isoforms of PGRs while the zebrafish has 
only one form. Thus, it is possible that the mechanisms regulating zebrafish Pgr 
expression may be slightly different. 
In late stage oocytes after 3 hours of treatment with E2, pgr mRNA expression 
levels were greater than controls. After 1.5 hours, Pgr expression also appeared elevated 
by E2, though not significantly. E2 is known to increase expression of Pgr in rat 
gonadotropes and the mouse mammary gland (Turgeon and Waring, 2000; Aupperlee and 
Haslam, 2007). In rat preovulatory follicles and eel pituitary cells, E2 may also act 
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indirectly by causing an increase in LH which serves to stimulate PGR expression (Natraj 
and Richards, 1993; Aroua et al., 2007).  
Not surprisingly, human chorionic gonadotropin (hCG), a combination of FSH 
and LH also elevated expression of pgr mRNA after 3 hours. Additionally, hCG 
significantly up-regulated pgr expression after 1.5 hours. LH/hCG is known to play a role 
in oocyte maturation and ovulation (Motola et al., 2006). These pituitary gonadotropins 
indirectly mediate these processes by controlling follicular production of steroidal 
mediators, such as E2 and DHP (Nagahama et al., 1995). In rats, studies have shown that 
ovulatory action of LH involves mediation by ovarian autocrine/paracrine EGF-like 
factors (Park et al., 2004; Ashkenazi et al., 2005). Mouse studies have demonstrated that 
increases in LH levels induce expression of a number of genes in ovarian follicular cells 
including progesterone  receptor (pgr) (Lydon et al., 1995). Expression of downstream 
target genes controlled by PGR then function in an autocrine/paracrine manner to control 
the ovulatory process (Kim et al., 2009) The ability of these hormones to regulate Pgr 
expression provides evidence for the importance of their actions during oocyte growth, 
maturation and ovulation in the zebrafish model. 
 No significant differences in expression were seen in early stage oocytes between 
the control and treatment with 17,20β-dihydroxy-4-pregnen-3-one (DHP), progesterone 
(P4), or human chorionic gonadotropin (hCG) after 1.5 hours. However, E2 significantly 
decreased pgr mRNA expression after 1.5 hours but no effect was seen at 3 hours. In 
contrast, E2 increases pgr gene expression in MCF-7 breast cancer cells in which eight 
estrogen response elements (EREs) have been identified within the progesterone receptor 
(pgr) gene (Boney-Montoya et al., 2010). Also, E2 has been shown to upregulate Pgr 
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levels in various tissues in humans, macaques and mice as well (Bethea and Widmann, 
1998; Petz et al., 2004; Aupperlee and Haslam, 2007). Combined with the lack of effect 
seen after 3 hours of E2 treatment, it seems likely that decreased expression of pgr 
transcripts at 1.5 hours is likely a transient response. Additionally, Pgr protein levels were 
approximately 3-fold greater than controls after 3 hours of E2 treatment. In MCF-7 cells, 
maximal levels of PGR mRNA and protein are not reached until after 72 hours of E2 
treatment (Nardulli et al., 1988; Read et al., 1988; Wei et al., 1988). 
After 3 hours, pgr mRNA expression appeared to increase with DHP and P4 
treatments. Though the change was not significant, both of these hormones are known 
activators of Pgr-mediated transcriptional activity (Hanna et al., 2010). Aupperlee and 
Haslam (2007) demonstrated upregulation of PR-B in mouse mammary glands after 
prolonged P4 treatment. However, studies in cultured bovine endometrial cells and rat 
gonadotropes have demonstrated that progesterone has a negative effect on PGR 
expression (Xiao and Goff, 1999; Turgeon and Waring, 2000). 
Conclusion 
In conclusion, Pgr was localized in the cytoplasm and follicular cells of early stage 
oocytes (stages I-II), but only in the follicular cells of stage IV oocytes. Expression levels 
of pgr mRNA varied throughout the daily reproductive cycle of zebrafish. Changes in 
expression occurred in early (stage I-II) oocytes and follicular cells but only in follicular 
cells of late (stage IV) oocytes. These findings are consistent with the known genomic 
role of PGRs in oocyte growth and ovulation, but not maturation. Finally, expression of 
pgr transcripts and Pgr protein were affected by several steroid hormones involved in 
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reproduction. Together, these results provide support for the roles of PGRs in oocyte 
growth and ovulation, but not final oocyte maturation. 
Interestingly, only one PGR has been identified in zebrafish compared to multiple 
isoforms identified in other fish, amphibian, bird, and mammalian species. This unique 
trait makes the study of zebrafish Pgr less complex and further study may provide insight 
into the evolutionary benefits of multiple isoforms. Additionally, the relationship, if any, 
between nuclear and membrane progesterone receptors remains to be elucidated to 
determine whether PGR plays an indirect role in the nongenomic process of oocyte 
maturation. 
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R4: GACAACCAGAAGCCTCATC   
F1: GGATCACCTTTCTGCGCT pgr 
Primer (5’ to 3’)  
    
 
Table 1 Primers used for RT-PCR amplification of zebrafish 
 nuclear progestin receptor (pgr). 
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R2: TCCACAGGTCAGAACTCC   
F2: ACAGACAGCATACACCGC pgr 
Primer (5’ to 3’)  
    
 
Table 2 Primers used for quantitative real-time PCR amplification 
of zebrafish nuclear progestin receptor (pgr).  
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Figure 1. Comparison of amino acid sequence identities of domains of zebrafish 
PGR and domains of PGRs from other vertebrates; also domains of other 
zebrafish nuclear receptors. The numbers below the line represent the amino acid 
position with respect to the translation starting site. (Hanna et. al, 2010) 
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N1 
100-112aa 
Figure 2. Schematic showing the localization of amino acids that were used for 
synthesizing a peptide in order to generate an antibody against zebrafish nuclear 
progestin receptor (Pgr). The numbers in and above the boxes represent the amino 
acid positions with respect to the translation starting site. 
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Figure 3. Staining of oocytes with propidium iodide for verification of 
follicular cell removal; follicular cells present (right) versus denuded occytes 
(left). (Hanna et al., 2010)  
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Figure 4. RT-PCR analysis of zebrafish nuclear progestin receptor (pgr) and β-actin 
(actb) in stage I-II denuded oocytes either unstained (left) or stained with propidium 
iodide (right). 
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Figure 5. RT-PCR analysis for localization of zebrafish nuclear progestin receptor 
(pgr) in early developmental (stage I-II) and late vitellogenic  oocytes (stage IV) and 
follicular cells. I-II: stage I-II, IV: stage IV, T: total oocyte samples include both 
follicular cells and enclosed oocytes, F : Follicular cells only,   D : denuded oocytes 
only, + : pgr plasmid used as a positive control in the PCR amplification. β-actin 
(actb) used as loading control.  
                T I-IV        T I-II        F I-II       D I-II          F IV        D IV             + 
actb 
pgr 
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Figure 6. Expression of zebrafish nuclear progestin receptor (pgr) transcripts in early  
developmental (stage I-II) and late vitellogenic oocytes (stage IV) analyzed by in situ. 
Picture A and C: pgr sense probe; Picture B and D: pgr antisense probe. Scale bar: 50 
µm. 
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Figure 7: Western analysis of the expression of zebrafish nuclear 
progestin receptor protein (Pgr) in follicular cell layers without oocytes 
(Follicle IV), denuded stage IV oocytes (w/o folli: without follicular 
cells), and stage IV follicular cell enclosed oocytes. Analyses of 
antibody specificity with (+) or without (-) pre-absorption of antibodies 
with the synthetic peptides used for antibody generation (right). Arrow 
indicates expected size of Pgr. (Hanna et al., 2010) 
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Figure 8. Expression of zebrafish nuclear progestin receptor( Pgr)  protein in early 
developmental (stage I-II) and late vitellogenic oocytes (stage IV) analyzed by 
immunocytochemistry using a specific zebrafish Pgr antibody developed against A/B 
region of Pgr. (A) Positive immunostaining in the nuclei and follicular cells of stage I-
II oocytes, arrow indicates nucleus of stage I oocyte;  (B) Positive immunostaining in 
the follicular cells of stage IV oocytes;  (C) Immunostaining of stage IV oocyte with 
pre-immune serum. Bar=50 µm 
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Figure 9. A representative standard curve for qRT-PCR analyses of zebrafish 
nuclear progestin receptor (pgr). The x-axis and y-axis represent Log 
Concentration (fmol/L) and Threshold Cycle (Ct) of a serially diluted (104 to 
1010 fold) plasmid DNA containing full-length zebrafish pgr cDNA inserts. 
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Figure 10. Daily changes of zebrafish nuclear progestin receptor (pgr) in denuded-
late  vitellogenic oocytes (DIV),  follicular cells of late vitellogenic oocytes (FIV), 
and follicular cells enclosed oocytes  of late vitellogenic stages (TIV) or early 
developmental stages (T I-II) analyzed by quantitative real-time PCR (qRT-PCR).  
Oocytes and follicular cells were collected at 6AM prior to the oocyte maturation 
and ovulation, and at 1PM and 9PM after the ovulation.  Different letters above the 
bars represent significant differences within each group (p < 0.05). Values are 
means ± SEM from at least three independent experiments. 
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Figure 11. Expression changes of zebrafish nuclear progestin receptor (pgr) transcript 
in  follicular cells enclosed stage IV oocytes (A) and follicular cells enclosed stage I-II  
oocytes (B) after 1.5 hours and 3 hours of treatment with 17,20β-dihydroxy-4-pregnen-
3-one (DHP), estrogen (E2), progesterone (P4), human chorionic gonadotropin (hCG), 
or with a vehicle (control) analyzed by quantitative real-time PCR (qRT-PCR). * 
p<0.05 compared to controls. Values are means ± SEM from three independent 
experiments. 
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Figure 12. Expression changes of zebrafish nuclear progestin receptor (Pgr) protein in 
follicular cells enclosed stage IV oocytes (A) and follicular cells enclosed stage I-II 
oocytes (B) after 1.5 hours and 3 hours of treatment with 17,20β-dihydroxy-4-pregnen-
3-one (DHP), estrogen (E2),  progesterone (P4), human chorionic gonadotropin (hCG), 
or with a vehicle (control) analyzed by Western blotting. * p<0.05 compared to 
controls. Values are means ± SEM from three independent experiments. 
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